Literature DB >> 23867472

Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.

Yongjun Yin1, Tomoko Betsuyaku, Joel R Garbow, Jinbai Miao, Ramaswamy Govindan, David M Ornitz.   

Abstract

Fibroblast growth factors (FGF) are expressed in many non-small cell lung carcinoma (NSCLC) primary tumors and derived cell lines, and mutations in FGF receptor 3 (FGFR3) have been identified in human lung adenocarcinoma. FGF9 has been implicated in the pathogenesis of NSCLC by synergizing with EGFR pathways or by providing an escape pathway mediating resistance to EGFR inhibition. To model pathogenic mechanisms mediated by FGF signals, we have established a mouse model in which FGF9 expression can be induced in adult lung epithelium. Here, we show that induced expression of FGF9 in adult lung leads to the rapid proliferation of distal airway epithelial cells that express the stem cell marker, Sca-1, and the proximal and distal epithelial markers, Sftpc and CC10, the rapid formation of Sftpc-positive adenocarcinomas, and eventual metastasis in some mice. Furthermore, we have identified FGFR3 as the obligate receptor mediating the FGF9 oncogenic signal. These results identify an FGF9-FGFR3 signal as a primary oncogenic pathway for lung adenocarcinoma and suggest that this pathway could be exploited for customized therapeutic applications for both primary tumors and those that have acquired resistance to inhibition of other signaling pathways. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867472      PMCID: PMC3778117          DOI: 10.1158/0008-5472.CAN-13-0495

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

2.  FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo.

Authors:  J C Clark; J W Tichelaar; S E Wert; N Itoh; A K Perl; M T Stahlman; J A Whitsett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-04       Impact factor: 5.464

3.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Authors:  Neali D Hendrix; Rong Wu; Rork Kuick; Donald R Schwartz; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

4.  Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.

Authors:  Hartmut Kuhn; Carmen Köpff; Jana Konrad; Alexander Riedel; Christian Gessner; Hubert Wirtz
Journal:  Lung Cancer       Date:  2004-05       Impact factor: 5.705

5.  microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.

Authors:  Jaeku Kang; Soo Young Lee; Sun Young Lee; Young Jin Kim; Jae Yong Park; Sun Jung Kwon; Moon Jun Na; Eun Jin Lee; Hyo Sung Jeon; Ji Woong Son
Journal:  Exp Ther Med       Date:  2011-10-14       Impact factor: 2.447

6.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

Authors:  Zhi Gang Li; Paul Mathew; Jun Yang; Michael W Starbuck; Amado J Zurita; Jie Liu; Charles Sikes; Asha S Multani; Eleni Efstathiou; Adriana Lopez; Jing Wang; Tina V Fanning; Victor G Prieto; Vikas Kundra; Elba S Vazquez; Patricia Troncoso; Austin K Raymond; Christopher J Logothetis; Sue-Hwa Lin; Sankar Maity; Nora M Navone
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

8.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

Authors:  Shigehisa Yanagi; Hiroyuki Kishimoto; Kohichi Kawahara; Takehiko Sasaki; Masato Sasaki; Miki Nishio; Nobuyuki Yajima; Koichi Hamada; Yasuo Horie; Hiroshi Kubo; Jeffrey A Whitsett; Tak Wah Mak; Toru Nakano; Masamitsu Nakazato; Akira Suzuki
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.

Authors:  F R Lamont; D C Tomlinson; P A Cooper; S D Shnyder; J D Chester; M A Knowles
Journal:  Br J Cancer       Date:  2010-11-30       Impact factor: 7.640

10.  Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.

Authors:  Hendrik Fischer; Ninon Taylor; Sigrid Allerstorfer; Michael Grusch; Gudrun Sonvilla; Klaus Holzmann; Ulrike Setinek; Leonilla Elbling; Heidelinde Cantonati; Bettina Grasl-Kraupp; Christine Gauglhofer; Brigitte Marian; Michael Micksche; Walter Berger
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

View more
  24 in total

1.  Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.

Authors:  Jie Luo; Bin Chen; Xian-Xiu Ji; Song-Wen Zhou; Di Zheng
Journal:  Tumour Biol       Date:  2015-08-28

2.  Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin.

Authors:  Robert D Guzy; Ivan Stoilov; Timothy J Elton; Robert P Mecham; David M Ornitz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

3.  Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases.

Authors:  Hao Yin; Matthew J Frontini; John-Michael Arpino; Zengxuan Nong; Caroline O'Neil; Yiwen Xu; Brittany Balint; Aaron D Ward; Subrata Chakrabarti; Christopher G Ellis; Robert Gros; J Geoffrey Pickering
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

4.  FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.

Authors:  Ming-Min Chang; Meng-Shao Lai; Siou-Ying Hong; Bo-Syong Pan; Hsin Huang; Shang-Hsun Yang; Chia-Ching Wu; H Sunny Sun; Jih-Ing Chuang; Chia-Yih Wang; Bu-Miin Huang
Journal:  Cancer Sci       Date:  2018-10-23       Impact factor: 6.716

5.  FGF receptors control alveolar elastogenesis.

Authors:  Rongbo Li; John C Herriges; Lin Chen; Robert P Mecham; Xin Sun
Journal:  Development       Date:  2017-11-09       Impact factor: 6.868

6.  FGF9 and FGF10 activate distinct signaling pathways to direct lung epithelial specification and branching.

Authors:  Yongjun Yin; David M Ornitz
Journal:  Sci Signal       Date:  2020-03-03       Impact factor: 8.192

7.  Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma.

Authors:  Daisuke Arai; Ahmed E Hegab; Kenzo Soejima; Aoi Kuroda; Kota Ishioka; Hiroyuki Yasuda; Katsuhiko Naoki; Kagawa Shizuko; Junko Hamamoto; Yongjun Yin; David M Ornitz; Tomoko Betsuyaku
Journal:  J Pathol       Date:  2014-12-17       Impact factor: 7.996

8.  Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

Authors:  Jeremy H Tchaicha; Esra A Akbay; Abigail Altabef; Oliver R Mikse; Eiki Kikuchi; Kevin Rhee; Rachel G Liao; Roderick T Bronson; Lynette M Sholl; Matthew Meyerson; Peter S Hammerman; Kwok-Kin Wong
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

9.  Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer.

Authors:  Ahmed E Hegab; Naofumi Kameyama; Aoi Kuroda; Shizuko Kagawa; Yongjun Yin; David Ornitz; Tomoko Betsuyaku
Journal:  J Vis Exp       Date:  2016-05-20       Impact factor: 1.355

10.  ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.

Authors:  Joanna DeSalvo; Yuguang Ban; Luyuan Li; Xiaodian Sun; Zhijie Jiang; Darcy A Kerr; Mahsa Khanlari; Maria Boulina; Mario R Capecchi; Juha M Partanen; Lin Chen; Tadashi Kondo; David M Ornitz; Jonathan C Trent; Josiane E Eid
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.